Clinical Trial Update: Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from the University of Ottawa examined treatment-resistant depression, hippocampal atrophy, and serotonin genetic polymorphisms and has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of Ottawa | Conditions: Major Depression | Phase 4 | Status: COMPLETED